Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
Clinical trial NCT03891979 · WITHDRAWN
Trial details
- NCT number
- NCT03891979
- Sponsor
- NYU Langone Health
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2020-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.